{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:44:29Z","timestamp":1711637069662},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/bor.0000000000000213","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T14:16:19Z","timestamp":1441203379000},"page":"586-594","source":"Crossref","is-referenced-by-count":8,"title":["Genetic advances in sporadic inclusion body myositis"],"prefix":"10.1097","volume":"27","author":[{"given":"Qiang","family":"Gang","sequence":"first","affiliation":[]},{"given":"Concei\u00e7\u00e3o","family":"Bettencourt","sequence":"additional","affiliation":[]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[]},{"given":"Michael G.","family":"Hanna","sequence":"additional","affiliation":[]},{"given":"Pedro M.","family":"Machado","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-9-88","article-title":"Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.","volume":"9","author":"Gang","year":"2014","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/WCO.0000000000000129","article-title":"Sporadic inclusion body myositis: new insights and potential therapy.","volume":"27","author":"Machado","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"Pt 4","key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/120.4.653","article-title":"An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.","volume":"120","author":"Sivakumar","year":"1997","journal-title":"Brain"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2169\/internalmedicine.42.1035","article-title":"Familial inclusion body myositis: a report on two Japanese sisters.","volume":"42","author":"Tateyama","year":"2003","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.2004.025494","article-title":"Familial inflammatory inclusion body myositis.","volume":"64","author":"Ranque-Francois","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.51.2.598","article-title":"Inclusion body myositis in twins.","volume":"51","author":"Amato","year":"1998","journal-title":"Neurology"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbadis.2014.08.007","article-title":"Hereditary inclusion-body myopathies.","volume":"1852","author":"Broccolini","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mus.20766","article-title":"Genetics of inclusion-body myositis.","volume":"35","author":"Needham","year":"2007","journal-title":"Muscle Nerve"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/1531-8249(200006)47:6<811::AID-ANA16>3.0.CO;2-9","article-title":"Partial laminin alpha2 chain deficiency in a patient with myopathy resembling inclusion body myositis.","volume":"47","author":"Di Blasi","year":"2000","journal-title":"Ann Neurol"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1994.tb06604.x","article-title":"HLA associations with inclusion body myositis.","volume":"98","author":"Garlepp","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(97)00245-2","article-title":"HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies.","volume":"84","author":"Koffman","year":"1998","journal-title":"J Neuroimmunol"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0039.2004.00310.x","article-title":"Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.","volume":"64","author":"Price","year":"2004","journal-title":"Tissue Antigens"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.","volume":"84","author":"OHanlon","year":"2005","journal-title":"Medicine"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jnnp.2007.138891","article-title":"Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.","volume":"79","author":"Needham","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nmd.2009.07.015","article-title":"Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.","volume":"19","author":"Mastaglia","year":"2009","journal-title":"Neuromusc Disord"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2012.05.003","article-title":"High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.","volume":"250","author":"Rojana-udomsart","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nmd.2006.02.002","article-title":"Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1.","volume":"16","author":"Scott","year":"2006","journal-title":"Neuromusc Disord"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jneuroim.2012.09.003","article-title":"Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC class II region in sporadic inclusion body myositis.","volume":"254","author":"Rojana-udomsart","year":"2013","journal-title":"J Neuroimmunol"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2012.04.021","article-title":"Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis.","volume":"250","author":"Scott","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.nmd.2013.09.008","article-title":"Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.","volume":"23","author":"Mastaglia","year":"2013","journal-title":"Neuromusc Disord"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archneurol.2010.88","article-title":"An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.","volume":"67","author":"Roses","year":"2010","journal-title":"Arch Neurol"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimers disease.","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenom J"},{"key":"R24-12-20210128","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nmd.2014.12.009","article-title":"Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.","volume":"25","author":"Weihl","year":"2015","journal-title":"Neuromusc Disord"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00415-011-5966-4","article-title":"A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes.","volume":"258","author":"Rohrer","year":"2011","journal-title":"J Neurol"},{"key":"R28-12-20210128","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbadis.2008.09.003","article-title":"VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder.","volume":"1782","author":"Kimonis","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng1332","article-title":"Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.","volume":"36","author":"Watts","year":"2004","journal-title":"Nature Genet"},{"key":"R30-12-20210128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000105158","article-title":"Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimers disease.","volume":"4","author":"Kaleem","year":"2007","journal-title":"Neuro-degen Dis"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00415-012-6439-0","article-title":"Clinical, pathological, and genetic mutation analysis of sporadic inclusion body myositis in Japanese people.","volume":"259","author":"Cai","year":"2012","journal-title":"J Neurol"},{"key":"R32-12-20210128","first-page":"e004552","article-title":"A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.","volume":"4","author":"Brady","year":"2014","journal-title":"Br Med J Open"},{"key":"R33-12-20210128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00005072-199507000-00012","article-title":"Mitochondrial DNA deletions in muscle fibers in inclusion body myositis.","volume":"54","author":"Oldfors","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"R34-12-20210128","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410390615","article-title":"Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients.","volume":"39","author":"Santorelli","year":"1996","journal-title":"Ann Neurol"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0960-8966(00)00144-9","article-title":"Mitochondrial DNA variants in inclusion body myositis.","volume":"10","author":"Kok","year":"2000","journal-title":"Neuromusc Disord"},{"key":"R37-12-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nmd.2014.12.010","article-title":"Mitochondrial pathology in inclusion body myositis.","volume":"25","author":"Lindgren","year":"2015","journal-title":"Neuromusc Disord"},{"key":"R38-12-20210128","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/nan.12149","article-title":"Mitochondrial and inflammatory changes in sporadic Inclusion Body Myositis.","volume":"41","author":"Rygiel","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R39-12-20210128","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature11922","article-title":"Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.","volume":"495","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"R40-12-20210128","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.neurobiolaging.2013.12.029","article-title":"Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.","volume":"35","author":"Cortese","year":"2014","journal-title":"Neurobiol Aging"},{"key":"R41-12-20210128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2014.04.012","article-title":"Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.","volume":"24","author":"Pinkus","year":"2014","journal-title":"Neuromusc Disord"},{"key":"R43-12-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimers disease.","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"R44-12-20210128","first-page":"1","article-title":"Using whole-exome sequencing to identify mutations of SQSTM1 and VCP in inclusion body myositis. Abstracts of the UK Neuromuscular Translational Research Conference 2015, 19th and 20th March 2015, Newcastle upon Tyne, UK.","volume":"25","author":"Gang","year":"2015","journal-title":"Neuromusc Disord"},{"key":"R45-12-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.phrs.2012.07.004","article-title":"p62SQSTM1A170: physiology and pathology.","volume":"66","author":"Komatsu","year":"2012","journal-title":"Pharmacol Res"},{"key":"R46-12-20210128","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tig.2012.06.008","article-title":"Relating human genetic variation to variation in drug responses.","volume":"28","author":"Madian","year":"2012","journal-title":"Trends Genet"},{"key":"R47-12-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2014.06.009","article-title":"Rare-variant association analysis: study designs and statistical tests.","volume":"95","author":"Lee","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R48-12-20210128","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/genes5041001","article-title":"Delivery of a clinical genomics service.","volume":"5","author":"Newman","year":"2014","journal-title":"Genes"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:34:07Z","timestamp":1620948847000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201511000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000213","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}